| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06 |
| filingDate |
2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01c5ab4627f858f265d2bd2c007521c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4a50fcc767f04b5766341d04792169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf4e0a95ce3759ee3b6d2a6272e58a4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a6617cc80f7d7d9269f6994f810e2e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9baf4afa3c9096b1570fac3341e7bf76 |
| publicationDate |
2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017235962-A1 |
| titleOfInvention |
Di-aliphatic substituted pegylated lipids |
| abstract |
The disclosure relates to di-aliphatic substituted PEGylated lipids and to methods of their preparation. The 5 disclosure also relates to lipid conjugates containing di aliphatic substituted PEGylated lipids, and to the use of di-aliphatic substituted PEGylated-lipid conjugates in drug delivery. W:\NRPortbl\GHMatters\MICHELES\9527053_1.docx 26/09/17 |
| priorityDate |
2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |